Gyeonggi-do, South Korea

Jang Hee Oh

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jang Hee Oh: Innovator in Inflammatory Disease Treatment

Introduction

Jang Hee Oh is a notable inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of medical science, particularly in the development of compositions aimed at improving inflammatory diseases. Her innovative work has the potential to enhance the quality of life for many individuals suffering from such conditions.

Latest Patents

Jang Hee Oh holds a patent for a composition designed to improve inflammatory diseases using ABH antigens. This invention focuses on enhancing the barrier function of epithelial tissues, such as skin, while also promoting aging resistance and skin elasticity. The composition is capable of modulating inflammatory reactions by influencing the expression and activity of ABH antigens. This advancement can be utilized in therapeutic agents aimed at treating diseases caused by inflammatory reactions, particularly in skin tissues.

Career Highlights

Throughout her career, Jang Hee Oh has been associated with Snur & Db Foundation, where she has been able to apply her research and innovations effectively. Her work has garnered attention for its potential applications in external preparations and cosmetics, targeting issues such as skin restoration, moisturization, wrinkle enhancement, and elasticity recovery.

Collaborations

Jang Hee Oh has collaborated with notable colleagues, including Ji-Yong Jung and Dong Hun Lee. These partnerships have contributed to the advancement of her research and the successful development of her patented compositions.

Conclusion

Jang Hee Oh's contributions to the field of inflammatory disease treatment through her innovative compositions highlight her role as a leading inventor. Her work not only addresses significant medical challenges but also opens new avenues for therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…